KMTSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends April 30
KESTRA MEDICAL TECHNOLOGIES, LTD.
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026
$29.37+2.13 (+7.82%)
Close on Oct 19, 2026
- Market cap
- $1.72B
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$4.76 (+19.34%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
KESTRA MEDICAL TECHNOLOGIES, LTD. grew revenue 60.7% to $106.73M over the twelve months to Jul 31, 2026. Free cash flow was -$122.79M.
Revenue
$106.73M
+60.7% vs. a year earlier
Operating income
-$143.52M
TTM Q1 2027
Free cash flow
-$122.79M
TTM Q1 2027
EPS, diluted
-$2.67
TTM Q1 2027
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jul 31, 2026
Valuation
- Market cap
- $1.72B
- P/E ratio
- –
- Price to sales
- 16.12
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- -7.14%
Fundamentals
- Revenue
- $106.73M
- Net income
- -$149.87M
- EPS, diluted
- -$2.67
- Free cash flow
- -$122.79M
- Diluted shares
- 59M
Four years at a glance
Fiscal years 2023 to 2026 and trailing twelve months, USD
Revenue
$106.73M+60.7% YoY
Gross profit
$57.51M+99.3% YoY
Operating income
-$143.52M
Net income
-$149.87M
EPS, diluted
-$2.67
Free cash flow
-$122.79M
Reported periodTrailing twelve months